JP2012502011A5 - - Google Patents

Download PDF

Info

Publication number
JP2012502011A5
JP2012502011A5 JP2011525575A JP2011525575A JP2012502011A5 JP 2012502011 A5 JP2012502011 A5 JP 2012502011A5 JP 2011525575 A JP2011525575 A JP 2011525575A JP 2011525575 A JP2011525575 A JP 2011525575A JP 2012502011 A5 JP2012502011 A5 JP 2012502011A5
Authority
JP
Japan
Prior art keywords
compound
growth hormone
group
binding protein
nhc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011525575A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012502011A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/061688 external-priority patent/WO2010029107A1/en
Publication of JP2012502011A publication Critical patent/JP2012502011A/ja
Publication of JP2012502011A5 publication Critical patent/JP2012502011A5/ja
Withdrawn legal-status Critical Current

Links

JP2011525575A 2008-09-09 2009-09-09 増加した安定性を有する成長ホルモンコンジュゲート Withdrawn JP2012502011A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08163958 2008-09-09
EP08163958.5 2008-09-09
PCT/EP2009/061688 WO2010029107A1 (en) 2008-09-09 2009-09-09 Growth hormone conjugate with increased stability

Publications (2)

Publication Number Publication Date
JP2012502011A JP2012502011A (ja) 2012-01-26
JP2012502011A5 true JP2012502011A5 (enExample) 2012-10-25

Family

ID=41210872

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011525575A Withdrawn JP2012502011A (ja) 2008-09-09 2009-09-09 増加した安定性を有する成長ホルモンコンジュゲート

Country Status (5)

Country Link
US (1) US20110263501A1 (enExample)
EP (1) EP2324056A1 (enExample)
JP (1) JP2012502011A (enExample)
CN (1) CN102149726A (enExample)
WO (1) WO2010029107A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2012134974A (ru) 2010-01-22 2014-02-27 Ново Нордиск Хелс Кеа Аг Стабилизированное соединение гормона роста
RU2605627C2 (ru) 2010-01-22 2016-12-27 Ново Нордиск Хелс Кеа Аг Гормоны роста с пролонгированной эффективностью in vivo
EP2788014B8 (en) * 2011-12-09 2019-10-23 Metabolic Pharmaceuticals Pty Ltd Use of growth hormone fragments
EP2981282B1 (en) 2013-04-05 2020-11-04 Novo Nordisk Health Care AG Growth hormone compound formulation
US10738338B2 (en) 2016-10-18 2020-08-11 The Research Foundation for the State University Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7049285B2 (en) * 2001-10-31 2006-05-23 Myung-Ok Park Biocompatible polymers including peptide spacer
US7524813B2 (en) * 2003-10-10 2009-04-28 Novo Nordisk Health Care Ag Selectively conjugated peptides and methods of making the same
ES2642214T3 (es) * 2004-01-21 2017-11-15 Novo Nordisk Health Care Ag Conjugación de péptidos mediante transglutaminasa
US20070105770A1 (en) * 2004-01-21 2007-05-10 Novo Nordisk A/S Transglutaminase mediated conjugation of peptides
WO2006042848A2 (en) * 2004-10-18 2006-04-27 Novo Nordisk A/S Growth hormone conjugates
EP1893239A2 (en) * 2005-06-15 2008-03-05 Novo Nordisk Health Care AG Transglutaminase mediated conjugation of growth hormone

Similar Documents

Publication Publication Date Title
JP2021526816A5 (enExample)
JP2020114818A5 (enExample)
US8299225B2 (en) Amidite for synthesizing modified nucleic acid and method for synthesizing modified nucleic acid
JP2014518063A5 (enExample)
CN1638809A (zh) 低分子量物质与修饰多糖的偶联
JP2016520574A (ja) 新規リンカー、その製造方法およびその応用
CN1227500A (zh) 药物复合物的制造方法
JP2013520986A5 (enExample)
AU2018329745A1 (en) Antibody-mediated delivery of Cas9 to mammalian cells
LU81881A1 (fr) Procede de preparation d'un derive n-acyle selectivement protege d'un antibiotique aminoglycosidique
TW200908996A (en) Hydrolysable polymeric Fmoc-linker
CN104877982B (zh) 制备肽/蛋白缀合物的方法和试剂
CN1646702A (zh) 用于治疗性寡核苷酸的蛋白质载体系统
TW200831527A (en) Method of peptide synthesis
WO2016047794A1 (ja) 疎水性ペプチドの製造法
CN119731335A (zh) 广谱病毒捕获纳米壳体
AU2022362053A1 (en) Compositions and methods for genome editing the neonatal fc receptor
CN110054658A (zh) 一种烟酰胺核糖的合成方法
CN1681535A (zh) 羟烷基淀粉－变应原偶联物
JP2010540488A5 (enExample)
JP4800771B2 (ja) 糖鎖リガンド複合体、およびそのリガンド複合体を用いたタンパク質の分析方法
CN110475801A (zh) 在末端具有多个羟基的聚氧乙烯衍生物的制造方法
US8951804B2 (en) Isolation of RNA-protein complexes using cross-linking reagents and oligonucleotides
EP2226314A1 (fr) Agents de reticulation
FR2952058A1 (fr) Procede de ligation native de polypeptides